Borosil Scientific Limited has informed the Exchange regarding Board meeting held on May 21, 2025.
BOROSCI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved audited financial results (standalone and consolidated) for Q4 and FY ended March 31, 2025. Standalone revenue from operations rose to Rs. 39,249.01 lakhs (FY25) from Rs. 35,645.97 lakhs (FY24), up about 10%, while standalone profit after tax grew to Rs. 3,501.66 lakhs from Rs. 3,145.93 lakhs (~11% growth). Consolidated revenue rose to Rs. 43,848.71 lakhs and consolidated PAT to Rs. 2,672.32 lakhs (~14% growth). The Board also approved seeking shareholder approval to raise up to Rs. 250 crores through QIP, FPO, FCCBs or other modes. Statutory auditor Chaturvedi & Shah LLP issued an unmodified (clean) opinion on both standalone and consolidated results. A note mentioned a Voluntary Retirement Scheme at the Nashik plant with financial impact to be recognized later. Operating cash flow surged, aided by Rs. 9,780.91 lakhs received under a Scheme of Arrangement.
Shareholders get a clean audit report, steady revenue and profit growth, and EPS rising to Rs. 3.94 (standalone) from Rs. 3.55. The Rs. 250 crore fund-raising plan could lead to dilution if executed, but gives the company flexibility for expansion. Stock may see a positive reaction given clean results, though investors should watch the loss-making subsidiary Goel Scientific Glass Works.